<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FENOPROFEN CALCIUM</span><br/>(fen-oh-proe'fen)<br/><span class="topboxtradename">Nalfon<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">analgesic, antipyretic</span>; <span class="classification">nsaid</span>; <span class="classification">cox-1</span><br/><b>Prototype: </b>Ibuprofen<br/><b>Pregnancy Category: </b>B (D in third trimester)<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>200 mg, 300 mg capsules; 600 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Exhibits antiinflammatory, analgesic, and antipyretic properties of an NSAID. Claimed to be comparable to aspirin in antiinflammatory
         activity and associated with lower incidence of adverse GI symptoms.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effectiveness evidenced within a few days with peak effect in 23 wk. Has nonsteroidal, antiinflammatory, antiarthritic
         properties which provides relief from mild to severe pain.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Antiinflammatory and analgesic effects in the symptomatic treatment of acute and chronic rheumatoid arthritis and osteoarthritis;
         relief of mild to moderate pain.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Juvenile rheumatoid arthritis, acute gouty arthritis, ankylosing spondylitis; fever associated with pulmonary tuberculosis,
         type A influenza, colds; neoplasms.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>History of nephrotic syndrome associated with aspirin or other <small>NSAID</small>s; patient in whom urticaria, severe rhinitis, bronchospasm, angioedema, nasal polyps are precipitated by aspirin or other
         <small>NSAID</small>s; significant renal or hepatic dysfunction; pregnancy (category B, category D in third trimester). Safety in lactation or
         children is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>History of upper GI tract disorders; hemophilia or other bleeding tendencies; compromised cardiac function, hypertension;
         impaired hearing.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Inflammatory Disease</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 300600 mg t.i.d. or q.i.d. (max: 3200 mg/d)<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 900 mg/m<sup>2</sup> in divided doses, may increase over 4 wk to 1.8 g/m<sup>2</sup> <br/><br/><span class="indicationtitle">Mild to Moderate Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200 mg q46h prn<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give on an empty stomach 3060 min before or 2 h after meals. Give with meals, milk, or antacid (prescribed) if patient
            experiences GI disturbances.
         </li>
<li>May crush tablets or empty capsule and mix with fluid or mix with food.</li>
<li>Store capsules and tablets in tightly closed containers at 15°30° C (59°86° F); avoid freezing.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Headache, drowsiness,</span> dizziness, fatigue, lassitude, tremor, confusion, insomnia, nervousness, depression. <span class="typehead">Special Senses:</span> Tinnitus, decreased hearing, deafness; blurred vision. <span class="typehead">GI:</span> <span class="speceff-common">Indigestion, nausea, vomiting,</span> anorexia, <span class="speceff-common">constipation,</span> diarrhea, flatulence, abdominal pain, dry mouth; infrequent: gastritis, peptic ulcer, <span class="speceff-life">GI bleeding</span>. <span class="typehead">Urogenital:</span> Dysuria, cystitis, hematuria, oliguria, azotemia, anuria, allergic nephritis, papillary necrosis, nephrotoxicity (rare). <span class="typehead">Hematologic:</span> (infrequent) Thrombocytopenia, <span class="speceff-life">hemolytic anemia, agranulocytosis, pancytopenia</span>. <span class="typehead">Skin:</span> (may or may not be hypersensitivity reaction) Pruritus, rash, purpura, increased sweating, urticaria. <span class="typehead">Body as a Whole:</span> Dyspnea, malaise, <span class="speceff-life">anaphylaxis</span>, edema. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Fenoprofen may prolong bleeding time; should not be given with <span class="classification">oral anticoagulants</span>, <b>heparin;</b> action and side effects of <b>phenytoin,</b> <span class="classification">sulfonylureas</span>, <span class="classification">sulfonamides</span>, and fenoprofen may be potentiated. <span class="typehead">Herbal:</span> <b>Feverfew,</b> <b>garlic,</b> <b>ginger,</b> <b>gingko</b> may increase bleeding potential. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 80% absorbed from GI tract. <span class="typehead">Onset:</span> 2 h. <span class="typehead">Peak:</span> 2 h. <span class="typehead">Duration:</span> 46 h. <span class="typehead">Distribution:</span> Small amounts distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted primarily in urine; some biliary excretion. <span class="typehead">Half-Life:</span> 3 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Baseline evaluations of Hct and Hgb, kidney and liver function.</li>
<li>Baseline and periodic auditory and ophthalmic examinations are recommended in patients receiving prolonged or high dose therapy.</li>
<li>Monitor for S&amp;S of GI bleeding.</li>
<li> 							Note: Dosage adjustment of fenoprofen may be required when phenobarbital is added to or withdrawn from patient's drug regimen. 						</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known; fenoprofen may cause dizziness
            and drowsiness.
         </li>
<li>Report immediately the onset of unexplained fever, rash, arthralgia, oliguria, edema, weight gain to physician. Possible symptoms
            of nephrotic syndrome are rapidly reversible if drug is promptly withdrawn.
         </li>
<li>Understand that alcohol and aspirin may increase risk of GI ulceration and bleeding tendencies; avoid both unless otherwise
            advised by physician.
         </li>
<li>Inform dentist or surgeon that you are taking fenoprofen because it may prolong bleeding time.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>